A retrospective evaluation of icotinib for safety and efficacy in Chinese patients with advanced non-small cell lung cancer.
Phase of Trial: Phase IV
Latest Information Update: 05 Dec 2015
At a glance
- Drugs Icotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 05 Dec 2015 New trial record